Title: Telemedicine as a catalyst for progress in pediatric oncology and immunology: Experience of dmitry rogachev national medical research center of pediatric hematology, oncology and immunology
Abstract:
The Dmitry Rogachev National Medical Research Center for Pediatric Hematology, Oncology, and Immunology is actively using telemedicine technologies to improve the quality and accessibility of care for children with cancer, hematological diseases, and immune disorders throughout the Russian Federation. This presentation will highlight the Center's experience using telemedicine as a catalyst for progress in pediatric oncology and immunology, focusing on key areas of impact: diagnosis, treatment planning, follow-up care, and education. The use of telemedicine technologies has demonstrated effectiveness in reducing the time to diagnosis, especially for patients in remote and low-income areas. Teleconsultations with specialists at the Rogachev Center have enabled local physicians to make faster, more accurate diagnoses, leading to earlier treatment initiation and improved outcomes. More than 80,000 telemedicine consultations were conducted between 2019 and 2025. Telemedicine also plays a key role in interdisciplinary treatment planning. Virtual tumor consultations and specialized conferences have facilitated collaboration between specialists from different regions, ensuring all patients have the opportunity to receive expert opinions and the most up-to-date treatment protocols. Remote monitoring of vital signs, medication adherence, and side effects using telemedicine platforms can improve patient adherence to treatment and reduce the need for frequent trips to the Center, which is particularly burdensome for children and their families. This integrated approach to telemedicine has the potential to improve the delivery of medical care for children with pediatric oncology and hematology in Russia, increasing treatment effectiveness and empowering both patients and healthcare providers. Our experience provides valuable lessons for other institutions seeking to implement or expand their own telemedicine programs. Additional data and specific examples from our work will be shared during the presentation.
